198 related articles for article (PubMed ID: 10069535)
1. Osteopontin (OPN) distribution in premalignant and malignant lesions of oral epithelium and expression in cell lines derived from squamous cell carcinoma of the oral cavity.
Devoll RE; Li W; Woods KV; Pinero GJ; Butler WT; Farach-Carson MC; Happonen RP
J Oral Pathol Med; 1999 Mar; 28(3):97-101. PubMed ID: 10069535
[TBL] [Abstract][Full Text] [Related]
2. Cloning of hamster osteopontin and expression distribution in normal tissues and experimentally induced oral squamous-cell carcinoma.
Jin H; Valverde P; Chen J
Arch Oral Biol; 2006 Mar; 51(3):236-45. PubMed ID: 16095557
[TBL] [Abstract][Full Text] [Related]
3. Shifts in cellular localization of moesin in normal oral epithelium, oral epithelial dysplasia, verrucous carcinoma and oral squamous cell carcinoma.
Kobayashi H; Sagara J; Masumoto J; Kurita H; Kurashina K; Taniguchi S
J Oral Pathol Med; 2003 Jul; 32(6):344-9. PubMed ID: 12787041
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin: a marker for invasive oral squamous cell carcinoma but not for potentially malignant epithelial dysplasias.
Routray S; Kheur SM; Kheur M
Ann Diagn Pathol; 2013 Oct; 17(5):421-4. PubMed ID: 23711950
[TBL] [Abstract][Full Text] [Related]
5. Differential immunohistochemical expression profiles of perlecan-binding growth factors in epithelial dysplasia, carcinoma in situ, and squamous cell carcinoma of the oral mucosa.
Hasegawa M; Cheng J; Maruyama S; Yamazaki M; Abé T; Babkair H; Saito C; Saku T
Pathol Res Pract; 2016 May; 212(5):426-36. PubMed ID: 26965914
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of SIBLING proteins and correlation with cognate MMP expression in oral cancer.
Ogbureke KU; Nikitakis NG; Warburton G; Ord RA; Sauk JJ; Waller JL; Fisher LW
Oral Oncol; 2007 Oct; 43(9):920-32. PubMed ID: 17306612
[TBL] [Abstract][Full Text] [Related]
7. Expression of p53 in oral mucosal hyperplasia, dysplasia and squamous cell carcinoma.
Kerdpon D; Rich AM; Reade PC
Oral Dis; 1997 Jun; 3(2):86-92. PubMed ID: 9467348
[TBL] [Abstract][Full Text] [Related]
8. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
[TBL] [Abstract][Full Text] [Related]
9. Immunolocalization of osteopontin in dysplasias and squamous cell carcinomas arising from oral epithelium.
Aravind T; Janardhanan M; Rakesh S; Savithri V; Unnikrishnan UG
J Oral Maxillofac Pathol; 2017; 21(1):18-23. PubMed ID: 28479681
[TBL] [Abstract][Full Text] [Related]
10. Distribution of tenascin in oral premalignant lesions and squamous cell carcinoma.
Tiitta O; Happonen RP; Virtanen I; Luomanen M
J Oral Pathol Med; 1994 Nov; 23(10):446-50. PubMed ID: 7532219
[TBL] [Abstract][Full Text] [Related]
11. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
Chen YK; Hsue SS; Lin LM
Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
[TBL] [Abstract][Full Text] [Related]
12. Two members of the SIBLING family of proteins, DSPP and BSP, may predict the transition of oral epithelial dysplasia to oral squamous cell carcinoma.
Ogbureke KU; Abdelsayed RA; Kushner H; Li L; Fisher LW
Cancer; 2010 Apr; 116(7):1709-17. PubMed ID: 20186700
[TBL] [Abstract][Full Text] [Related]
13. The role of Cripto-1 in the tumorigenesis and progression of oral squamous cell carcinoma.
Yoon HJ; Hong JS; Shin WJ; Lee YJ; Hong KO; Lee JI; Hong SP; Hong SD
Oral Oncol; 2011 Nov; 47(11):1023-31. PubMed ID: 21824804
[TBL] [Abstract][Full Text] [Related]
14. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
15. [Expression of osteopontin mRNA in oral squamous cell carcinoma and normal oral mucosa].
Lu XZ; Yin XM; Feng YY; Duan LQ; Chen WT; Zhang CP
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1165-7. PubMed ID: 18676253
[TBL] [Abstract][Full Text] [Related]
16. The implication of osteopontin (OPN) expression and genetic polymorphisms of OPN promoter in oral carcinogenesis.
Chiu YW; Tu HF; Wang IK; Wu CH; Chang KW; Liu TY; Kao SY
Oral Oncol; 2010 Apr; 46(4):302-6. PubMed ID: 20219412
[TBL] [Abstract][Full Text] [Related]
17. Id proteins are overexpressed in human oral squamous cell carcinomas.
Nishimine M; Nakamura M; Mishima K; Kishi M; Kirita T; Sugimura M; Konishi N
J Oral Pathol Med; 2003 Jul; 32(6):350-7. PubMed ID: 12787042
[TBL] [Abstract][Full Text] [Related]
18. Reduction of syndecan-1 expression is associated with dysplastic oral epithelium.
Soukka T; Pohjola J; Inki P; Happonen RP
J Oral Pathol Med; 2000 Aug; 29(7):308-13. PubMed ID: 10947246
[TBL] [Abstract][Full Text] [Related]
19. Expression of granulocyte colony-stimulating factor receptor and platelet-derived endothelial cell growth factor in oral and oropharyngeal precancerous lesions.
Sunaga H; Fujieda S; Tsuzuki H; Asamoto K; Fukuda M; Saito H
Anticancer Res; 2001; 21(4B):2901-6. PubMed ID: 11712784
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of osteopontin expression in oral squamous cell carcinoma.
Jeyasivanesan DL; Mohamed SP; Pandiar D; Basheer S
Indian J Dent Res; 2019; 30(4):539-543. PubMed ID: 31745049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
